tirzepatide no brasil Mounjaro terá preço perto de R$ 1.700 início da venda no Brasil, diz fonte Anvisa aprova Tirzepatida para diabetes

From a pragmatic point of view, a successful weight loss drug that doesnt require you to diet and exercise probably isnt great for all the guilt sign ups powering PLNTs ability to make a buck (although I fully support people changing their diet and exercise, there is the question of if they were going to do that they wouldnt have needed the drug in the first place...)

The FDA has logged hundreds of adverse-event reports tied to compounded GLP-1s, many involving self-dosing errors from multidose vials

M.SharmaS

But Martin and others say cutting off coverage to save costs is short-sighted because the treatments save money in the long-term by reducing the cost of treating expensive obesity-related conditions, like cardiovascular disease and type 2 diabetes